Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Fortress biotech, inc. crawled time : 13:30 save search
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
Published: 2024-03-04 (Crawled : 13:30) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: 2.47%
H: 5.02%
C: -8.03%
disease biotech million grant therapeutics therapy
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
Published: 2024-02-22 (Crawled : 13:30) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: 1.73%
H: 1.14%
C: -0.57%
ATXI | $0.088 -6.68% 1.3M
|
Health Technology
|
| O: -2.95%
H: 2.62%
C: -1.93%
baer-101 drug publication research preclinical therapeutics
Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
Published: 2024-01-11 (Crawled : 13:30) - globenewswire.com
MBIO | $0.3501 35K
|
Health Technology
|
| O: 0.76%
H: 9.84%
C: 3.03%
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: 0.0%
H: 0.51%
C: -4.12%
conference
Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
Published: 2024-01-11 (Crawled : 13:30) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: 0.0%
H: 0.51%
C: -4.12%
CKPT | $1.45 0.69% 29K
|
Health Technology
|
| O: 1.57%
H: 1.55%
C: -2.58%
conference therapeutics
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
Published: 2024-01-05 (Crawled : 13:30) - globenewswire.com
DERM | $3.4 -3.96% -3.36% 11
|
|
| O: 2.82%
H: 4.7%
C: -1.17%
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: -0.8%
H: 4.03%
C: -2.42%
dfd-29 fda drug corporation treat medical application
Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol
Published: 2024-01-04 (Crawled : 13:30) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: -2.42%
H: 14.88%
C: 3.31%
ATXI | $0.088 -6.68% 1.3M
|
Health Technology
|
| O: 62.95%
H: 23.82%
C: 20.11%
fda therapeutics agreement study
Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
Published: 2024-01-02 (Crawled : 13:30) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: -0.33%
H: 2.33%
C: -10.33%
ATXI | $0.088 -6.68% 1.3M
|
Health Technology
|
| O: 8.7%
H: 0.0%
C: -8.57%
aj201 treatment trial therapeutics
Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Published: 2023-12-29 (Crawled : 13:30) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: -16.71%
H: 2.95%
C: -7.1%
nasdaq biotech million direct offering
Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting
Published: 2023-12-11 (Crawled : 13:30) - globenewswire.com
MBIO | $0.3501 35K
|
Health Technology
|
| O: -2.6%
H: 7.33%
C: -4.67%
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: 0.64%
H: 3.18%
C: -4.46%
mb-106 meeting
Cyprium Therapeutics, a Fortress Biotech Subsidiary Company, Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease, to Sentynl Therapeutics, a Wholly-owned Subsidiary of Zydus Lifesciences Ltd.
Published: 2023-12-06 (Crawled : 13:30) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: 0.75%
H: 7.43%
C: 4.09%
cutx-101 candidate biotech transfer treatment lifesciences
Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab with New U.S. Patent Issuance
Published: 2023-12-05 (Crawled : 13:30) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: -3.07%
H: 7.51%
C: 5.53%
CKPT | $1.45 0.69% 29K
|
Health Technology
|
| O: -0.35%
H: 2.43%
C: 0.69%
patent cosibelimab therapeutics
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce CUTX-101, Copper Histidinate, Data to be Presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting
Published: 2022-03-21 (Crawled : 13:30) - biospace.com/
AZNCF | News | $135.35 400
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: -4.79%
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: 2.03%
H: 0.66%
C: -5.96%
AZN | News | $75.37 5.86% 2.7M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
cutx-101 america genetic therapeutics biotech iot
QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation
Published: 2022-02-11 (Crawled : 13:30) - globenewswire.com
DERM | $3.4 -3.96% -3.36% 11
|
|
| O: 0.76%
H: 3.98%
C: -0.95%
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
qbrexza approval corporation one milestone
BioSpace Movers & Shakers, Feb. 4
Published: 2022-02-04 (Crawled : 13:30) - biospace.com/
PPRUF | News | $345.01 1.47% 37.56% 0
|
Consumer Non-Durables
|
| O: -1.71%
H: 1.0%
C: -3.53%
MYMX 4 | $0.0016 0.0% 4.8M
|
Manufacturing
|
| O: -2.15%
H: 0.31%
C: -2.2%
PPRUY | News | $34.9595 3.46% -0.11% 120
|
Manufacturing
|
| O: -0.12%
H: 1.38%
C: 0.7%
JNJ | News | $147.46 -0.72% 820K
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
TENX | $3.56 1.71% 0.28% 0
|
Health Technology
|
| O: -4.71%
H: 5.77%
C: 3.55%
SNY | News | $46.61 -2.27% -2.21% 220K
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
PINC | $21.12 0.43% 0.45% 0
|
Health Services
|
| O: -0.33%
H: 0.0%
C: 0.0%
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
MESO | $6.1 -1.93% 25K
|
Health Technology
|
| O: -1.73%
H: 0.0%
C: 0.0%
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: -2.54%
H: 0.0%
C: 0.0%
BDTX | $4.99 -1.38% 42K
|
Health Technology
|
| O: -4.05%
H: 0.0%
C: 0.0%
AUTL | $4.105 -2.49% 770K
|
Health Technology
|
| O: 5.71%
H: 0.0%
C: 0.0%
APTX | $0.061 21.31% 7.8M
|
Health Services
|
| O: 0.68%
H: 0.0%
C: 0.0%
space spac
Fortress Biotech Announces Initiation of Phase 2 Clinical Trial of Triplex for Adults Co-Infected with HIV and CMV
Published: 2021-12-16 (Crawled : 13:30) - globenewswire.com
AZNCF | News | $135.35 400
|
Health Technology
|
| O: 1.5%
H: 1.71%
C: 1.71%
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: -5.34%
AZN | News | $75.37 5.86% 2.7M
|
Health Technology
|
| O: 2.13%
H: 1.9%
C: 1.73%
phase 2 trial biotech iot hiv infections
Mustang Bio Added to the NASDAQ Biotechnology Index
Published: 2021-12-16 (Crawled : 13:30) - globenewswire.com
MBIO | $0.3501 35K
|
Health Technology
|
| O: 6.15%
H: 1.58%
C: -3.16%
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: -5.34%
technology nasdaq index biotech iot
Journey Medical Corporation Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights
Published: 2021-12-10 (Crawled : 13:30) - globenewswire.com
DERM | $3.4 -3.96% -3.36% 11
|
|
| O: 3.7%
H: 7.57%
C: 1.86%
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
financial results results
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of Rolling Submission of a New Drug Application for CUTX-101, Copper Histidinate, for Treatment of Menkes Disease
Published: 2021-12-07 (Crawled : 13:30) - globenewswire.com
AZNCF | News | $135.35 400
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -2.48%
FBIO | $1.79 -1.11% -1.4% 0
|
Health Technology
|
| O: 7.0%
H: 0.0%
C: 0.0%
AZN | News | $75.37 5.86% 2.7M
|
Health Technology
|
| O: -2.08%
H: 1.18%
C: 1.13%
new drug treatment application drug therapeutics disease biotech iot submission
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M
|
Consumer Services
BRFH 4 | $1.99 80.91% 13M
|
Manufacturing
LICN | $1.0 78.57% 3.3M
|
BOF | $1.915 63.68% 620K
|
MTC | $3.62 61.61% 790K
|
Technology Services
AMST | $3.13 56.5% 500K
|
Technology Services
ACON | $0.3595 24.83% 3.5M
|
n/a
ILAG | $0.669 23.89% 13M
|
CDTX | News | $14.57 18.55% 330K
|
Health Technology
MNY | $2.11 17.22% 180K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.